Discontinuation report BONEFOS
Report ID | 28705 |
Drug Identification Number | 01984845 |
Brand name | BONEFOS |
Common or Proper name | clodronate disodium |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLODRONATE DISODIUM |
Strength(s) | 400MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 120 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-03-31 |
Actual discontinuation date | 2018-03-27 |
Remaining supply date | 2018-03-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-09 | English | Compare |
v2 | 2017-11-16 | English | Compare |
v3 | 2017-11-16 | French | Compare |
v4 | 2018-04-02 | English | Compare |
v5 | 2018-04-02 | English | Compare |
Showing 1 to 5 of 5